Scotland · NHS Scotland MSAN
Methylphenidate prolonged-release tablets
MSAN(2024)48 · Level 3 · issued 23 Aug 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Methylphenidate prolonged-release tablet brands are in limited supply and intermittent regional | Limited supply | — |
| 2. Lisdexamfetamine (Elvanse®, Elvanse Adult®) capsules remain available and can support | Available | — |
| 4. Methylphenidate (Equasym® XL) modified-release capsules remain available but cannot | Available | — |
| as lisdexamfetamine capsules remain available, consider appropriateness of prescribing as | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:48
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
4f1c006fe2b7681b6f5dc9e7d9056d0b59794622f0232ecf847109e08c104da8sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-48.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.